Roland S.
- Country
- Germany
- Department
- Hematology/Oncologic clinic
Research Overview
- Randomized Phase II Study of Teclistamab + Daratumumab‑Lenalidomide‑Dexamethasone (Tec‑DRd) vs Daratumumab‑Lenalidomide‑Dexamethasone (DVRd) in Transplant‑Eligible NDMM
- Phase III Randomized, Placebo-Controlled Study of Venetoclax with Induction and Consolidation Chemotherapy in Newly Diagnosed AML or MDS-EB2 Patients
- Phase II Randomized Study of MB-CART2019.1 Versus Standard Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Ineligible for High-Dose Chemotherapy
Data & Insights
Has run more than one trial at 196 of 356 partner sites.
Specializations
Hematologic Malignancies
This investigator specializes in treating various forms of blood cancers, with particular emphasis on acute myeloid leukemia (AML) and its genetic variants. Their research encompasses novel therapeutic approaches for patients with different risk profiles and genetic mutations.
- Multiple Myeloma Treatment Innovation
- Acute Lymphoblastic Leukemia Management
- Advanced Hodgkin Lymphoma Therapy
The investigator focuses on developing treatment strategies for both newly diagnosed and treatment-resistant cases.
Targeted Therapies
Their work involves evaluating innovative targeted therapeutic approaches, including the use of antibody-drug conjugates and bispecific antibodies in various hematologic conditions.
- Novel Drug Combinations
- Immunotherapy Applications
- Personalized Treatment Approaches
Special attention is given to developing treatments for elderly patients and those unsuitable for intensive chemotherapy regimens.
Treatment Optimization
The investigator works on optimizing therapeutic protocols for various blood cancers, with particular focus on maintenance therapy strategies and reduced-toxicity treatments.
- Chemotherapy Optimization
- Treatment Response Assessment
- Long-term Disease Management
Research includes evaluation of minimal residual disease and progression-free survival outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.